Fundraising FoxImmuneOnco
1 known investors
Find your way into ImmuneOnco
Sign up to see every warm intro you have to ImmuneOnco
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ImmuneOnco team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ImmuneOnco Biopharmaceuticals is a Shanghai-founded clinical-stage biotech developing bispecific antibodies and Fc-fusion proteins for immuno-oncology and other diseases. It is publicly listed on the Hong Kong Stock Exchange.
Investors · 1
Frequently asked questions
- What does ImmuneOnco do?
- ImmuneOnco Biopharmaceuticals is a Shanghai-founded clinical-stage biotech developing bispecific antibodies and Fc-fusion proteins for immuno-oncology and other diseases. It is publicly listed on the Hong Kong Stock Exchange.
- Who are ImmuneOnco's investors?
- ImmuneOnco's investors include Curative Ventures.